Global Stem Cells Market by Cell Source (Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, Cord Blood/Embryonic Stem Cells), Type (Allogeneic Stem Cell Therapy, Autologous), Therapeutic Application - Forecast 2024-2030- Product Image

Sale

Global Stem Cells Market by Cell Source (Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, Cord Blood/Embryonic Stem Cells), Type (Allogeneic Stem Cell Therapy, Autologous), Therapeutic Application - Forecast 2024-2030

Report
189 Pages
March 2024
Region: Global
360iResearch™
ID: 4857951

UP TO €851EUR$875USD£729GBP OFF until Dec 31^st 2024

The Stem Cells Market size was estimated at USD 237.23 million in 2023, USD 277.13 million in 2024, and is expected to grow at a CAGR of 16.91% to reach USD 708.40 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Stem Cells Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Stem Cells Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Stem Cells Market, highlighting leading vendors and their innovative profiles. These include Advanced Cell Technology, Inc., AlloSource, Inc., Anterogen Co., Ltd., Bioheart Inc., BioTime, Inc., BrainStorm Cell Therapeutics Inc., Celgene Corporation, Cellartis AB, CellGenix GmbH, Cellular Engineering Technologies Inc., Gamida Cell Ltd, Gilead Sciences, Inc., Holostem Terapie Avanzate Srl, JCR Pharmaceuticals Co., Ltd., and Lonza Group AG.

Market Segmentation & Coverage

This research report categorizes the Stem Cells Market to forecast the revenues and analyze trends in each of the following sub-markets:

Cell Source
- Adipose Tissue-Derived Mesenchymal Stem Cells
- Bone Marrow-Derived Mesenchymal Stem Cells
- Cord Blood/Embryonic Stem Cells
Type
- Allogeneic Stem Cell Therapy
  - Acute Graft-Versus-Host Disease
  - Musculoskeletal Disorders
  - Surgeries
  - Wounds & Injuries
- Autologous
  - Cardiovascular Diseases
  - Gastrointestinal Diseases
  - Wounds and Injuries
Therapeutic Application
- Cardiovascular Diseases
- Gastrointestinal Diseases
- Musculoskeletal Disorders
- Surgeries
- Wounds & Injuries

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Stem Cells Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Stem Cells Market?
What are the technology trends and regulatory frameworks in the Stem Cells Market?
What is the market share of the leading vendors in the Stem Cells Market?
Which modes and strategic moves are suitable for entering the Stem Cells Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Stem Cells Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing awareness related to the potential stem cell therapy for effective disease management
5.1.1.2. Introduction of advanced Genome-based cell analysis techniques
5.1.1.3. Increasing investment for the development of stem cell therapies
5.1.1.4. Infrastructural development related to stem cell banking and processing
5.1.2. Restraints
5.1.2.1. Loosely defined regulatory guidelines for commercialization and development
5.1.2.2. Associated social-ethical issues
5.1.3. Opportunities
5.1.3.1. Supportive regulations across developing countries
5.1.3.2. Emergence of IPSCs as effective alternative to ESCs
5.1.4. Challenges
5.1.4.1. Concern regarding limited technical experts
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
5.10.1. Supply Chain Analysis

6. Stem Cells Market, by Cell Source

6.1. Introduction
6.2. Adipose Tissue-Derived Mesenchymal Stem Cells
6.3. Bone Marrow-Derived Mesenchymal Stem Cells
6.4. Cord Blood/Embryonic Stem Cells

7. Stem Cells Market, by Type

7.1. Introduction
7.2. Allogeneic Stem Cell Therapy
7.3.1. Acute Graft-Versus-Host Disease
7.3.2. Musculoskeletal Disorders
7.3.3. Surgeries
7.3.4. Wounds & Injuries
7.3. Autologous
7.4.1. Cardiovascular Diseases
7.4.2. Gastrointestinal Diseases
7.4.3. Wounds and Injuries

8. Stem Cells Market, by Therapeutic Application

8.1. Introduction
8.2. Cardiovascular Diseases
8.3. Gastrointestinal Diseases
8.4. Musculoskeletal Disorders
8.5. Surgeries
8.6. Wounds & Injuries

9. Americas Stem Cells Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Stem Cells Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Stem Cells Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

13.1. Key Company Profiles
13.1.1. Advanced Cell Technology, Inc.
13.1.2. AlloSource, Inc.
13.1.3. Anterogen Co., Ltd.
13.1.4. Bioheart Inc.
13.1.5. BioTime, Inc.
13.1.6. BrainStorm Cell Therapeutics Inc.
13.1.7. Celgene Corporation
13.1.8. Cellartis AB
13.1.9. CellGenix GmbH
13.1.10. Cellular Engineering Technologies Inc.
13.1.11. Gamida Cell Ltd
13.1.12. Gilead Sciences, Inc.
13.1.13. Holostem Terapie Avanzate Srl
13.1.14. JCR Pharmaceuticals Co., Ltd.
13.1.15. Lonza Group AG
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. STEM CELLS MARKET RESEARCH PROCESS
FIGURE 2. STEM CELLS MARKET SIZE, 2022 VS 2030
FIGURE 3. STEM CELLS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. STEM CELLS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. STEM CELLS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. STEM CELLS MARKET DYNAMICS
FIGURE 7. STEM CELLS MARKET SIZE, BY CELL SOURCE, 2022 VS 2030 (%)
FIGURE 8. STEM CELLS MARKET SIZE, BY CELL SOURCE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. STEM CELLS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 10. STEM CELLS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2022 VS 2030 (%)
FIGURE 12. STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS STEM CELLS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 14. AMERICAS STEM CELLS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES STEM CELLS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 16. UNITED STATES STEM CELLS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. STEM CELLS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 22. STEM CELLS MARKET SHARE, BY KEY PLAYER, 2022

List of Tables

TABLE 1. STEM CELLS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. STEM CELLS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL STEM CELLS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 6. STEM CELLS MARKET SIZE, BY ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. STEM CELLS MARKET SIZE, BY BONE MARROW-DERIVED MESENCHYMAL STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. STEM CELLS MARKET SIZE, BY CORD BLOOD/EMBRYONIC STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 10. STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 12. STEM CELLS MARKET SIZE, BY ACUTE GRAFT-VERSUS-HOST DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. STEM CELLS MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. STEM CELLS MARKET SIZE, BY SURGERIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. STEM CELLS MARKET SIZE, BY WOUNDS & INJURIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. STEM CELLS MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 18. STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. STEM CELLS MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. STEM CELLS MARKET SIZE, BY WOUNDS AND INJURIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. STEM CELLS MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. STEM CELLS MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. STEM CELLS MARKET SIZE, BY SURGERIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. STEM CELLS MARKET SIZE, BY WOUNDS & INJURIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. CANADA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 44. CANADA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. CANADA STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 46. CANADA STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 47. CANADA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. MEXICO STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 49. MEXICO STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. MEXICO STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 51. MEXICO STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 52. MEXICO STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES STEM CELLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. CHINA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 71. CHINA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. CHINA STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 73. CHINA STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 74. CHINA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. INDIA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 76. INDIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. INDIA STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 78. INDIA STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 79. INDIA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. JAPAN STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 86. JAPAN STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. JAPAN STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 88. JAPAN STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 89. JAPAN STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. THAILAND STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 116. THAILAND STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. THAILAND STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 118. THAILAND STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 119. THAILAND STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 131. DENMARK STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 132. DENMARK STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. DENMARK STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 134. DENMARK STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 135. DENMARK STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. EGYPT STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 137. EGYPT STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. EGYPT STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 139. EGYPT STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 140. EGYPT STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. FINLAND STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 142. FINLAND STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 143. FINLAND STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 144. FINLAND STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 145. FINLAND STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. FRANCE STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 147. FRANCE STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. FRANCE STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 149. FRANCE STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 150. FRANCE STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. GERMANY STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 152. GERMANY STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 153. GERMANY STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 154. GERMANY STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 155. GERMANY STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. ITALY STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 162. ITALY STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 163. ITALY STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 164. ITALY STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 165. ITALY STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. NORWAY STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 177. NORWAY STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 178. NORWAY STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 179. NORWAY STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 180. NORWAY STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. POLAND STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 182. POLAND STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 183. POLAND STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 184. POLAND STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 185. POLAND STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. QATAR STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 187. QATAR STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 188. QATAR STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 189. QATAR STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 190. QATAR STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. SPAIN STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 207. SPAIN STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 208. SPAIN STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 209. SPAIN STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 210. SPAIN STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. TURKEY STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 222. TURKEY STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 223. TURKEY STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 224. TURKEY STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 225. TURKEY STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. STEM CELLS MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 237. STEM CELLS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 238. STEM CELLS MARKET LICENSE & PRICING

Companies Mentioned

Advanced Cell Technology, Inc.
AlloSource, Inc.
Anterogen Co., Ltd.
Bioheart Inc.
BioTime, Inc.
BrainStorm Cell Therapeutics Inc.
Celgene Corporation
Cellartis AB
CellGenix GmbH
Cellular Engineering Technologies Inc.
Gamida Cell Ltd
Gilead Sciences, Inc.
Holostem Terapie Avanzate Srl
JCR Pharmaceuticals Co., Ltd.
Lonza Group AG

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	189
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 277.13 Million
Forecasted Market Value ( USD ) by 2030	$ 708.4 Million
Compound Annual Growth Rate	16.9%
Regions Covered	Global
No. of Companies Mentioned	15

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3283EUR$3,374USD£2,812GBP €3648EUR$3,749USD£3,125GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4159EUR$4,274USD£3,562GBP €4621EUR$4,749USD£3,958GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5034EUR$5,174USD£4,313GBP €5594EUR$5,749USD£4,792GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5910EUR$6,074USD£5,063GBP €6567EUR$6,749USD£5,625GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7661EUR$7,874USD£6,563GBP €8513EUR$8,749USD£7,292GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Stem Cell Therapy Market by Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), Cell Source (Adipose Tissue-Derived MSCs, Bone Marrow-Derived MSCs, Placental / Umbilical Cord-Derived MSCs), Therapeutic Application, End-User - Forecast 2024-2030

Global Mesenchymal Stem Cells Market by Type (Allogeneic, Autologous), Indication (Bone & Cartilage Repair, Cancer, Cardiovascular Disease), Source of Isolation, Application - Forecast 2023-2030

Stem Cell Therapy Market by Type (Allogeneic, Autologous), Cell Source (Adipose Tissue, Bone Marrow, Placenta/Umbilical Cord), Therapeutic Application (Musculoskeletal, Wounds, Surgeries, Inflammatory, Autoimmune, Cardiovascular) - Global Forecast to 2028

Mesenchymal Stem Cell Market Report: Trends, Forecast and Competitive Analysis to 2030

Mesenchymal Stem Cells Market Size, Share & Trends Analysis Report By Product & Services, By Workflow, By Type, By Source Of Isolation, By Indication, By Application, By Region, And Segment Forecasts, 2023 - 2030